看看查看全文
来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-097236 Size: 6 KB 网页链接
$Agile Therapeutics(AGRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-20-096161 Size: 10 KB 网页链接
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-096165 Size: 5 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001558370-20-010710 Act: 34 Size: 449 KB 网页链接
$Agile Therapeutics(AGRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-20-010330 Act: 34 Size: 4 MB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-20-010323 Act: 34 Size: 232 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, item 8.01 Accession Number: 0001558370-20-007854 Act: 34 Size: 27 KB 网页链接
$Agile Therapeutics(AGRX)$ 内部交易: 2020-06-22,CEO,ALTOMARI ALFRED ,期权,50000普通股, $1.76
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-076109 Size: 6 KB 网页链接
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-072483 Size: 7 KB 网页链接